Navigation Links
Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study
Date:10/11/2007

Conference Call Today at 9 am ET

BEDMINSTER, N.J., Oct. 11 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) today reported top-line results from the company's Phase 3 study of its investigational drug GATTEX(TM) (teduglutide, recombinant GLP-2) in which 83 patients with short bowel syndrome (SBS) received either a low dose of GATTEX, (0.05 milligrams/kilogram/day), a higher dose (0.10 mg/kg/day) or placebo. The clinical efficacy endpoint of the study was a reduction in parenteral nutrition (PN) of at least 20% comparing baseline to weeks 16 to 24, measured as a graded response to capture reductions up to 100%. In an intent-to-treat analysis, forty-six percent (46%) of patients receiving the lower dose of GATTEX (N=35) responded and achieved a highly statistically significant reduction in PN compared to placebo (p=0.007), with two patients gaining independence from and discontinuing PN by week 20 and a third patient discontinuing PN at the end of treatment. Twenty-five percent (25%) of patients receiving the higher dose of GATTEX (N=32) responded and showed a trend in the difference between the treatment group and placebo, but this did not reach statistical significance (p=0.161). The study's criteria for conducting the statistical analysis of the primary endpoint required that the results for the high-dose group show statistical significance before the results of the low-dose group could be considered. However, given the drug's orphan designation in SBS and the statistically strong (p=0.007) and clinically meaningful findings in the low-dose group, the company intends to meet with the FDA to discuss the path to regulatory approval for GATTEX.

Dr. Stephen O'Keefe, profes
'/>"/>

SOURCE NPS Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... China   , July 2, 2015 /PRNewswire/ ... laboratory in Hong Kong has ... BGI Hong Kong facility is the first clinical next-generation-sequencing ... China , meeting the highest standard in clinical ... CFR Part 11 compliant laboratory process, and multiple ISO ...
(Date:7/2/2015)... Agreement reinforces ...   ViiV Healthcare and Desano Pharmaceuticals (Desano) ... China of dolutegravir. The agreement will ... (API), and will allow ViiV Healthcare to offer a competitive ... name Tivicay®) for China and a ...
(Date:7/1/2015)... EDISON, N.J. , July 1, 2015 ... company focused on the development and commercialization of targeted ... the Cantor Fitzgerald Inaugural Healthcare Conference taking place in ... 8, 2015 at Le Parker Meridien Hotel. ... provide an overview of the Company,s business during his ...
Breaking Medicine Technology:BGI Receives Accreditation from the College of American Pathologists (CAP) 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 3ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 4ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 5ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 6ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2
(Date:7/3/2015)... ... 2015 , ... " Selfie on a Stick ” was featured on NewsWatch ... products available to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, ... documenting memories. , Almost every smartphone has an incredibly powerful camera built into it. ...
(Date:7/3/2015)... ... ... Celebrity Dresses is currently running a promotion through July 30th. Anyone who orders party ... get 10% discount on orders that are over $100. , The promotion is automatically ... or remember redemption codes. , There is a low price guarantee at The ...
(Date:7/2/2015)... ... 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening ... store located in the Lone Star State. The premium frozen yogurt chain was listed ... The store, which opened July 1 at Duke’s Travel Plaza, is located at:, 30176 ...
(Date:7/2/2015)... ... July 02, 2015 , ... When Walker Parking Consultants ... University of Minnesota, they knew it would save the university energy and maintenance ... choice: the total energy savings after installation was an impressive 89 percent, which ...
(Date:7/2/2015)... ... July 02, 2015 , ... In 2012, Patrick Achebe realized that the gift of poetry was ... down to write his first poem, and three years later he was publishing an entire ... worth sharing with the world. "I have always believed that the best way to lift ...
Breaking Medicine News(10 mins):Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2
... has detected on Sunday five new suspected cases of avian flu ... where the deadly virus was first isolated in October.// ... in a village of Padina showed presence of bird flu. ... strain. ,Avian flu has been found in birds in ...
... been claimed in treating AIDS patients using a herbal concoction ... blood cell count. // ,Dr P L Meenakshisundaram, ... ,Herbal medicine helped HIV patients to gain weight and their ... research and clinical trials done over a period ranging from ...
... of Washington University writes in his latest book Doctor’s ... has been a great scientist, inventor, publisher and statesman.// ... education has contributed a lot to preventive and modern ... America during the 18th Century in a period where ...
... actress Catherine Zeta Jones has made a New Year's resolution ... afraid of the impact her deadly habit will have on ... because her two children, Dylan-five and two-year-old Cary are approaching ... every little thing around. ,I have to stop as ...
... Doctor Robin Warren, the Australian Nobel Prize winners for medicine ... glitzy ceremony at Stockholm yesterday. // ,The ... belief in their concept. Professor Marshall and Dr Warren were ... and not by stress or lifestyle changes as previously believed. ...
... conducted by Steven H. Woolf, M.D., professor and director of ... reported that it will be fruitful // and more lives ... medical facilities and provided the existing facilities to the public. ... of Health (NIH) to improve treatment modalities of which only ...
Cached Medicine News:Health News:Stop spending on new treatments; allocate funds to improve the existing treatments. 2
... generation access device - XPOSE 4 - ... The XPOSE 4 Device is designed to ... surgery and to easily position and access ... both apical and non-apical placement on the ...
... ACROBAT SUV vacuum stabilizer from Guidant. ... ease of use. The newest members of ... stability with outstanding anastomotic site visibility ... our FlexLink technology on a stronger ...
... in 1992, ABIOMED's BVS 5000 has grown to ... system in the world to support recoverable hearts. ... U.S. Food and Drug Administration for all patients ... to make advances with the BVS 5000, expanding ...
... Dissector has application for use in the ... extraperitoneal spaces such as the retroperitoneal, preperitoneal, ... used in surgical procedures requiring dissection of ... of a quality conduit through a single ...
Medicine Products: